We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Tag: myocardial infarction
MedXY News
EnglishTag

myocardial infarction

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Targeting the CCND1-PDK4 Axis to Promote Reparative Macrophage Phenotype and Mitigate Post-Myocardial Infarction Cardiac Remodeling
CardiologyMetabolic Reprogrammingマクロファージ極性化

Targeting the CCND1-PDK4 Axis to Promote Reparative Macrophage Phenotype and Mitigate Post-Myocardial Infarction Cardiac Remodeling

By MedXY|Sep 19, 2026

This article discusses the role of cyclin D1 (CCND1) in promoting reparative macrophage transition post-myocardial infarction, highlighting its therapeutic potential in reducing adverse cardiac remodeling through metabolic reprogramming.

Evaluating Targeted Vitamin D Supplementation Post-Myocardial Infarction: Insights from the TARGET-D Trial
Cardiologycardiovascular events
TARGET-D trial

Evaluating Targeted Vitamin D Supplementation Post-Myocardial Infarction: Insights from the TARGET-D Trial

By MedXY|Sep 17, 2026

The TARGET-D trial investigated whether vitamin D supplementation, titrated to achieve serum levels >40-80 ng/mL, reduces major adverse cardiovascular events after myocardial infarction but found no significant benefit in the primary com

Comparing 0/1-Hour vs 0/3-Hour High-Sensitivity Troponin Pathways for Suspected Acute Coronary Syndrome in Real-World Practice
Cardiologyaccelerated diagnostic pathwaysemergency department

Comparing 0/1-Hour vs 0/3-Hour High-Sensitivity Troponin Pathways for Suspected Acute Coronary Syndrome in Real-World Practice

By MedXY|Sep 17, 2026

This randomized trial evaluates the safety and efficiency of the ESC 0/1-hour versus 0/3-hour high-sensitivity troponin pathways in suspected acute coronary syndrome, showing noninferior safety but no significant improvement in rapid discha

Stent Retriever Thrombectomy Reduces Infarct Size in High-Thrombus Myocardial Infarction: Insights from the NATURE Trial
CardiologyInfarct SizeStent Retriever Thrombectomy

Stent Retriever Thrombectomy Reduces Infarct Size in High-Thrombus Myocardial Infarction: Insights from the NATURE Trial

By MedXY|Sep 6, 2026

The NATURE trial demonstrates that stent retriever thrombectomy combined with conventional PCI significantly reduces infarct size in STEMI patients with large thrombus burden, without increasing short-term adverse events.

Refining Myocardial Infarction Diagnosis: A Novel Causal Endotype-Based Classification Beyond Type 1 and Type 2 MI
Cardiologycausal endotypesmyocardial infarction

Refining Myocardial Infarction Diagnosis: A Novel Causal Endotype-Based Classification Beyond Type 1 and Type 2 MI

By MedXY|Sep 1, 2026

This study introduces a causal endotype-based classification of myocardial infarction, revealing distinct underlying mechanisms and clinical outcomes beyond the traditional type 1/type 2 framework, potentially improving MI diagnosis and man

Evolving Impact of Implantable Cardioverter-Defibrillators on Mortality Post-Myocardial Infarction: Insights from the PROFID Study
Cardiologyimplantable cardioverter-defibrillatormortality reduction

Evolving Impact of Implantable Cardioverter-Defibrillators on Mortality Post-Myocardial Infarction: Insights from the PROFID Study

By MedXY|Aug 29, 2026

The PROFID study reveals a declining mortality benefit from primary prevention implantable cardioverter-defibrillators in post-myocardial infarction patients with reduced ejection fraction over recent decades, highlighting changing clinical

Harnessing the Vagus Nerve: A Novel Frontier in Myocardial Infarction Management
CardiologyCardioprotectionmyocardial infarction

Harnessing the Vagus Nerve: A Novel Frontier in Myocardial Infarction Management

By MedXY|Aug 27, 2026

This article explores the vital role of the vagus nerve in modulating myocardial infarction outcomes through autonomic regulation, reflex pathways, and cardioprotective mechanisms, highlighting translational potential from experimental mode

Association of Adherence to Various Dietary Patterns With Mortality Among Survivors of Myocardial Infarction: An Evidence-Based Review
CardiologyDietary patternsmyocardial infarction

Association of Adherence to Various Dietary Patterns With Mortality Among Survivors of Myocardial Infarction: An Evidence-Based Review

By MedXY|Aug 26, 2026

Post-MI adherence to diverse healthy dietary patterns is consistently linked to reduced mortality and cardiovascular events, underscoring the importance of diet quality in secondary prevention among MI survivors.

Silent Killers: Unveiling the Hidden Cardiac Pathologies Behind Sudden Cardiac Death
CardiologyOccult Cardiac Diseasesudden cardiac death

Silent Killers: Unveiling the Hidden Cardiac Pathologies Behind Sudden Cardiac Death

By MedXY|Aug 18, 2026

This study reveals that two-thirds of community sudden cardiac deaths occur in individuals without diagnosed cardiac disease, with half harboring occult myocardial infarction or dilated cardiomyopathy, underscoring the need for improved det

Pregnancy-Associated SCAD in Focus: What the iSCAD Registry Reveals About a Rare but High-Stakes Cause of MI in Women
CardiologySCADPregnancy

Pregnancy-Associated SCAD in Focus: What the iSCAD Registry Reveals About a Rare but High-Stakes Cause of MI in Women

By MedXY|Aug 18, 2026

The iSCAD Registry study highlights distinctive reproductive and psychosocial features among women with pregnancy-associated SCAD, underscoring the need for individualized counseling, heightened diagnostic suspicion, and multidisciplinary f

Macrophage circHIPK2 Silencing Reduces Post-Infarction Inflammation and Fibrosis and Improves Cardiac Recovery
Allergy & ImmunologycircHIPK2Macrophages

Macrophage circHIPK2 Silencing Reduces Post-Infarction Inflammation and Fibrosis and Improves Cardiac Recovery

By MedXY|Jun 10, 2026

A 2026 European Heart Journal study identifies macrophage circHIPK2 as a regulator of post-MI inflammation and fibrosis, with macrophage-targeted silencing improving cardiac remodeling in mice and showing translational promise in human myoc

Macrophage circHIPK2 After Myocardial Infarction: A New RNA Node Linking Inflammation, Stress Granules, and Fibrotic Remodelling
Clinical UpdatescircHIPK2Macrophages

Macrophage circHIPK2 After Myocardial Infarction: A New RNA Node Linking Inflammation, Stress Granules, and Fibrotic Remodelling

By MedXY|Jun 10, 2026

A 2026 European Heart Journal study identifies macrophage circHIPK2 as a regulator of post-MI inflammation and fibrosis, integrating circular RNA biology with macrophage polarization, stress-granule signaling, and emerging immune-targeted R

Higher Resting Heart Rate Still Signals Risk After Myocardial Infarction, and Stopping β-Blockers Raises Heart Rate Without Identifying a Safe Subgroup
Cardiologybeta-blockersheart rate

Higher Resting Heart Rate Still Signals Risk After Myocardial Infarction, and Stopping β-Blockers Raises Heart Rate Without Identifying a Safe Subgroup

By MedXY|Jun 10, 2026

A secondary analysis of ABYSS shows that in stable post-MI patients with preserved ejection fraction, higher heart rate remains prognostic and β-blocker interruption increases heart rate by about 10–13 bpm while worsening outcomes across he

A Genome-First Study of Familial Hypercholesterolemia in African and European Ancestry Individuals
CardiologyAfrican ancestryFamilial Hypercholesterolaemia

A Genome-First Study of Familial Hypercholesterolemia in African and European Ancestry Individuals

By MedXY|Jun 10, 2026

A genome-first study found similar rates of pathogenic FH variants in African and European ancestry groups, but uncertain variants were more common and potentially more harmful in African ancestry individuals, highlighting the need for more

Genome-First Data Suggest Familial Hypercholesterolemia Is Equally Prevalent Across African and European Ancestry Groups, but Underclassified in African Ancestry Patients
CardiologyFamilial HypercholesterolaemiaGenetic Ancestry

Genome-First Data Suggest Familial Hypercholesterolemia Is Equally Prevalent Across African and European Ancestry Groups, but Underclassified in African Ancestry Patients

By MedXY|May 31, 2026

A large multi-cohort genome-first study found similar prevalence of pathogenic FH variants across ancestries, but more VUSs and greater LDL-C and myocardial infarction risk among African ancestry individuals, highlighting likely underclassi

Prior Myocardial Infarction and Cognitive Decline: Insights from the REGARDS Cohort
Cardiologycardiovascular riskcognitive decline

Prior Myocardial Infarction and Cognitive Decline: Insights from the REGARDS Cohort

By MedXY|May 16, 2026

In the REGARDS cohort, prior myocardial infarction, including silent MI, was linked to faster long-term cognitive decline, suggesting heart attack history may help identify people at risk for future cognitive impairment.

A New hs-cTnT Generation 6 Assay Matches Generation 5 for Myocardial Infarction Diagnosis While Labeling Fewer Patients as Myocardially Injured
CardiologyDiagnostic accuracyemergency department

A New hs-cTnT Generation 6 Assay Matches Generation 5 for Myocardial Infarction Diagnosis While Labeling Fewer Patients as Myocardially Injured

By MedXY|May 9, 2026

In suspected myocardial infarction, hs-cTnT-gen6 showed diagnostic accuracy comparable to gen5, produced fewer myocardial injury classifications, and supported highly sensitive ESC 0/1-hour and 0/2-hour rule-out and rule-in pathways using a

Epigenetic Regulation of Myocardial Inflammation: The Role of Macrophage PRMT9 and STAT1 Degradation in Acute Myocardial Infarction
Cardiologymyocardial infarctionPRMT9

Epigenetic Regulation of Myocardial Inflammation: The Role of Macrophage PRMT9 and STAT1 Degradation in Acute Myocardial Infarction

By MedXY|May 12, 2026

This review explores how PRMT9-mediated symmetric dimethylation of STAT1 serves as a critical check on proinflammatory macrophage activation, offering a novel therapeutic target for mitigating cardiac injury following myocardial infarction.

Revolutionary Sixth-Generation Troponin Assay Doubles Early MI Rule-Out Capacity
Cardiologyemergency medicinemyocardial infarction

Revolutionary Sixth-Generation Troponin Assay Doubles Early MI Rule-Out Capacity

By MedXY|Apr 24, 2026

A novel sixth-gen hs-cTnT assay with a 13 ng/L threshold safely identified twice as many low-risk MI patients at ED presentation vs fifth-gen assays, achieving >99.5% NPV in multinational validation.

STEMI and NSTEMI Are Not the Same in Type 1 Diabetes: Finnish Cohort Reveals Distinct Risk Patterns
Cardiologymyocardial infarctionNSTEMI

STEMI and NSTEMI Are Not the Same in Type 1 Diabetes: Finnish Cohort Reveals Distinct Risk Patterns

By MedXY|Apr 1, 2026

In Finnish adults with type 1 diabetes, STEMI and NSTEMI showed distinct incidence trends and risk profiles. NSTEMI was more common overall and linked to dyslipidemia and advanced microvascular disease, whereas impaired eGFR tracked more wi

1 / 3
123
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities